![](\"https:\/\/www.bayoocare.com\/wp-content\/uploads\/sites\/7\/2026\/02\/5.jpg\" "\\"5\\"")
<\/span><\/div><\/div><\/div>Contract management for medical devices<\/h2><\/div>As a legal manufacturer, we at BAYOOCARE not only assume an advisory function, but also bear regulatory responsibility for medical devices ourselves. This perspective distinguishes us fundamentally from pure consulting service providers. We know from our own experience which contractual regulations work in practice, which risks notified bodies scrutinize in audits and how contracts must be structured in order not only to be formally correct, but also to be implemented in day-to-day business. <\/p>\n<\/div>
Contact us now<\/span><\/a><\/div><\/div><\/div><\/div><\/div>Contract management for medical devices<\/h1><\/div>As a legal manufacturer, we at BAYOOCARE not only assume an advisory function, but also bear regulatory responsibility for medical devices ourselves. This perspective distinguishes us fundamentally from pure consulting service providers. We know from our own experience which contractual regulations work in practice, which risks notified bodies scrutinize in audits and how contracts must be structured in order not only to be formally correct, but also to be implemented in day-to-day business. <\/p>\n<\/div>
Contact us now<\/span><\/a><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div><\/div>In the medical device sector, contracts are far more than just commercial agreements. They are an integral part of your compliance structure and must reflect the requirements of the Medical Device Regulation (MDR), the Medical Device Law Implementation Act (MPDG), ISO 13485 and, where applicable, FDA regulations in a legally compliant manner. The regulatory requirements for medical devices have increased considerably in recent years. When the MDR came into force on May 26, 2021, the obligations for all economic operators along the supply chain were redefined and tightened. Article 10 MDR in particular requires manufacturers to establish and maintain a documented quality management system, which also includes the contractual management of all outsourced processes and supplier relationships. <\/p>\n
Our contract management translates regulatory requirements into practicable, audit-proof and resilient agreements that clearly define responsibilities and strengthen your compliance structure in the long term.<\/p>\n<\/div>
Preparation and review of regulatory contracts<\/h2><\/div>Every contract in the medical device sector must ensure that all parties involved can fulfill their legal and normative obligations. We draw up and review contracts taking into account the specific requirements of your product, your risk class and your market region. We systematically take into account the requirements of MDR Article 10 (QMS requirements), ISO 13485 (quality management) and ISO 14971 (risk management) in order to translate regulatory and technical requirements into clear contractual obligations, documentation requirements and escalation paths. <\/p>\n
A key benefit of our legal manufacturer perspective is that we ensure consistency between your contracts, your quality management system and your technical documentation. Contracts that are developed in isolation from the QMS often lead to inconsistencies that become problematic in audits. We ensure that contractual agreements are seamlessly integrated into your existing processes and that audit trails are fully traceable. This significantly reduces regulatory risks such as deviations during audits by notified bodies and creates clear responsibilities that facilitate audits. <\/p>\n
Our contracts precisely define which party is responsible for which aspects of product safety, vigilance and post-market surveillance. This is particularly important in complex supply chains or OEM-PLM constellations, where the MDR imposes significantly stricter requirements than the previous MDD. We also take into account liability aspects and product liability risks, which will become even more relevant from December 2026 due to the new Product Liability Directive (EU) 2024\/2853. <\/p>\n<\/div><\/div><\/div>
![](\"https:\/\/www.bayoocare.com\/wp-content\/uploads\/sites\/7\/2026\/02\/7.jpg\" "\\"7\\"")
<\/span><\/div><\/div><\/div>Supplier and service contracts: Quality assurance agreements under the MDR<\/h2><\/div>Supplier contracts in the MedTech sector are subject to special requirements, as suppliers have a direct influence on product quality and therefore on patient safety. The MDR requires manufacturers to carry out a risk-based assessment and qualification of their suppliers as well as complete documentation of these processes. Quality assurance agreements (QAAs) are central components of the quality management system in accordance with MDR and ISO 13485. <\/p>\n
We design and review quality assurance agreements that contain all the elements required by regulations: Product quality requirements, test procedures and acceptance criteria, documentation obligations and change management, audit rights and monitoring mechanisms, traceability in accordance with Article 25 MDR as well as regulations on supplier evaluation and re-evaluation. Particularly important is the consideration of Article 120 (3) MDR, which places specific requirements on contracts with economic operators that have to be implemented since May 2021. <\/p>\n
Our quality assurance agreements are designed to be MDR-compliant and can be seamlessly integrated into your existing QM system. We support you in risk-based supplier selection in accordance with ISO 14971 and define clear processes for monitoring and re-evaluating suppliers in the contract. If desired, we can assume overall responsibility as a legal manufacturer and ensure that your supplier contracts fully reflect the regulatory chain of responsibility. This is particularly relevant if critical product components or processes are outsourced or if suppliers themselves do not have ISO 13485 certification. <\/p>\n<\/div>
Contracts for clinical trials: CRO contracts, sponsor obligations and subcontractors<\/h2><\/div>Clinical trials are required much more frequently under the MDR than under the previous MDD, particularly for products in risk class III and implantable devices. The contractual design of clinical trial agreements, CRO service contracts and subcontractor agreements is complex and requires precise regulations on responsibilities and regulatory obligations. <\/p>\n<\/div><\/div><\/div>
- <\/i><\/span>\n
Contracts with contract research organizations (CROs) and trial sites must clearly describe delegated sponsor obligations, quality requirements according to GCP (Good Clinical Practice) and ISO 14155, data integrity and data protection according to GDPR, safety reporting and vigilance obligations as well as monitoring and audit rights. A key question here is whether the CRO concludes contracts with trial sites in its own name or in the name of the sponsor, how changes to the study protocol are approved and how sponsor rights can be enforced in the event of deviations or breaches of contract. <\/p>\n<\/div><\/li>
- <\/i><\/span>\n
The use of subcontractors by CROs requires special attention. Contracts must contain clear reservations of consent by the sponsor, regulate the transfer of regulatory obligations to subcontractors and ensure that accountability to the sponsor is maintained. We structure and review clinical trial agreements, CRO service contracts and subcontractor agreements with a focus on regulatory compliance and liability reduction. In doing so, we systematically check the alignment of contracts with study protocols, GCP requirements and regulatory obligations as a sponsor or legal manufacturer. <\/p>\n<\/div><\/li>
- <\/i><\/span>\n
A particularly critical aspect is the definition of clear communication and escalation paths in the event of deviations, serious adverse events (SAE\/SADE) and audit findings. We define in the contract who has to inform which bodies and when, how reporting obligations to authorities and ethics committees are fulfilled and how these processes are documented. This prevents gaps in responsibility and ensures that all parties involved can fulfill their regulatory obligations in good time. <\/p>\n<\/div><\/li><\/ul><\/div><\/div>
Contact us<\/h3><\/div>Are you planning to place a medical device on the market and looking for an experienced legal manufacturer? Contact us for a non-binding consultation. Together we will develop the right strategy for your medical device. <\/p>\n<\/div>
Your contact to us<\/span><\/a><\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div><\/div>Ongoing contract and compliance management throughout the product life cycle<\/h2><\/div><\/div><\/div>Contracts are not static documents. They must be regularly reviewed and adapted to new regulatory requirements, updated standards and changes to internal processes. MDR updates, new MDCG guidelines, changes in harmonized standards or QMS adjustments may require contract amendments. Systematic contract management is therefore essential for audit and inspection capability and contributes to continuous compliance throughout the entire product life cycle. <\/p>\n
We organize a structured contract register with compliance relevance for you that links contracts with products, processes and risk assessments. This register enables you to track which contractual regulations apply to which products at any time, when contracts expire and where action is required. <\/p>\n<\/div><\/div><\/div>
\nWe undertake periodic contract reviews, implement trigger monitoring for regulatory changes, supplier changes or CAPAs and derive any necessary adjustments. This prevents contracts from becoming outdated or conflicting with current regulatory requirements. <\/p>\n<\/div>\n
The preparation and monitoring of audits and inspections is particularly important. Notified bodies and authorities regularly check how contracts support your quality, vigilance and compliance processes. We support you in providing evidence and prepare the relevant contract documents in such a way that auditors can quickly verify compliance. Our lifecycle approach ensures that your contract management remains consistent and compliant even in the event of product changes, expansions to the product portfolio or market entries into new regions. <\/p>\n<\/div><\/div><\/div>
BAYOOCARE as your partner for regulatory
\ncontract management<\/p><\/h2><\/div><\/div><\/div>
Our contract management combines regulatory expertise with practical implementation experience as a legal manufacturer. We not only understand the requirements of the MDR, ISO 13485 and other relevant regulations in theory, but also live them every day in our own responsibility for medical devices. This unique perspective enables us to draft contracts that are not only formally correct, but also work in everyday operations and can be lived by all parties involved. <\/p>\n
Our range of services includes the conception, creation and review of all contract-relevant documents in the MedTech sector. We structure complex contractual landscapes for supply chains, OEM-PLM constellations or international distribution structures. We assist you in contract negotiations with suppliers, CROs or sales partners and ensure that minimum regulatory requirements are met. If desired, we can assume overall responsibility as a legal manufacturer and act as a contracting party ourselves if this is advantageous for your market strategy or compliance structure. <\/p>\n
Our support in integrating contract management into your existing systems is particularly valuable. We link contracts with your QMS, your risk management documentation and your technical documentation so that consistent and seamless verification is possible. This integrated approach minimizes audit risks and creates the basis for sustainable compliance that will also withstand future regulatory changes. <\/p>\n<\/div><\/div><\/div>
Your next steps<\/h2><\/div>Would you like to make your contract landscape MDR-compliant, have existing contracts checked for compliance or need support with complex contract negotiations? Contact us for a non-binding consultation. We will analyse your specific situation and work with you to develop a solution that minimizes your regulatory risks and strengthens your compliance structure in the long term. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
Frequently asked questions<\/h2><\/div><\/div><\/div>Contract management raises many questions. We have answered the most common ones for you. Your question is not listed? Please feel free to contact us. <\/p>\n<\/div><\/div><\/div>
![](\"https:\/\/www.bayoocare.com\/wp-content\/uploads\/sites\/7\/2025\/01\/BAYOOCARE-Favicon.png\" "\\"BAYOOCARE")
<\/span><\/div><\/div><\/div><\/i><\/i><\/span>What is a quality assurance agreement (QAA) and why is it necessary for medical devices?<\/span><\/a><\/h4><\/div>A quality assurance agreement is a contract between the manufacturer and supplier that regulates all quality-related requirements, test procedures and responsibilities. The MDR and ISO 13485 require manufacturers to carry out a documented, risk-based assessment of their suppliers and to contractually safeguard all outsourced processes. QAAs precisely define which quality standards the supplier must comply with and create the legal basis for audits and change management. <\/div><\/div><\/div><\/i><\/i><\/span>How has the MDR changed the requirements for contracts with suppliers?<\/span><\/a><\/h4><\/div>\nThe MDR has significantly tightened the requirements. The former Article 11(7) of the MDD, which allowed for simplified OEM PLM regulations, has been removed. Today, every economic operator whose name appears on the packaging bears full manufacturer responsibility, including their own conformity assessment procedure. Contracts must therefore regulate in detail who is responsible for technical documentation, vigilance, post-market surveillance and UDI registration. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>What must a contract with a CRO for clinical trials contain?<\/span><\/a><\/h4><\/div>\nA CRO agreement must precisely describe all tasks delegated by the sponsor, including study planning, monitoring, data management and safety reporting. Compliance with GCP and ISO 14155, responsibilities for contracts with trial sites, audit rights of the sponsor and regulations on data ownership and subcontractor use are key. The contract should also define clear escalation paths in the event of protocol deviations or serious adverse events. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>How often do medical device contracts need to be reviewed and updated?<\/span><\/a><\/h4><\/div>\nContracts should be reviewed both on an ad hoc and periodic basis. Occasions include changes to regulations such as MDR updates, product changes, QMS adjustments or audit findings with CAPAs. We recommend a periodic review at least every two to three years, especially for critical suppliers and CRO contracts. A structured contract register with trigger monitoring helps to identify and implement necessary updates in good time. <\/p>\n<\/div><\/div><\/div>
As a legal manufacturer, we at BAYOOCARE not only assume an advisory function, but also bear regulatory responsibility for medical devices ourselves. This perspective distinguishes us fundamentally from pure consulting service providers. We know from our own experience which contractual regulations work in practice, which risks notified bodies scrutinize in audits and how contracts must be structured in order not only to be formally correct, but also to be implemented in day-to-day business. <\/p>\n<\/div>
Contract management for medical devices<\/h1><\/div>As a legal manufacturer, we at BAYOOCARE not only assume an advisory function, but also bear regulatory responsibility for medical devices ourselves. This perspective distinguishes us fundamentally from pure consulting service providers. We know from our own experience which contractual regulations work in practice, which risks notified bodies scrutinize in audits and how contracts must be structured in order not only to be formally correct, but also to be implemented in day-to-day business. <\/p>\n<\/div>
Contact us now<\/span><\/a><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div><\/div>In the medical device sector, contracts are far more than just commercial agreements. They are an integral part of your compliance structure and must reflect the requirements of the Medical Device Regulation (MDR), the Medical Device Law Implementation Act (MPDG), ISO 13485 and, where applicable, FDA regulations in a legally compliant manner. The regulatory requirements for medical devices have increased considerably in recent years. When the MDR came into force on May 26, 2021, the obligations for all economic operators along the supply chain were redefined and tightened. Article 10 MDR in particular requires manufacturers to establish and maintain a documented quality management system, which also includes the contractual management of all outsourced processes and supplier relationships. <\/p>\n
Our contract management translates regulatory requirements into practicable, audit-proof and resilient agreements that clearly define responsibilities and strengthen your compliance structure in the long term.<\/p>\n<\/div>
Preparation and review of regulatory contracts<\/h2><\/div>Every contract in the medical device sector must ensure that all parties involved can fulfill their legal and normative obligations. We draw up and review contracts taking into account the specific requirements of your product, your risk class and your market region. We systematically take into account the requirements of MDR Article 10 (QMS requirements), ISO 13485 (quality management) and ISO 14971 (risk management) in order to translate regulatory and technical requirements into clear contractual obligations, documentation requirements and escalation paths. <\/p>\n
A key benefit of our legal manufacturer perspective is that we ensure consistency between your contracts, your quality management system and your technical documentation. Contracts that are developed in isolation from the QMS often lead to inconsistencies that become problematic in audits. We ensure that contractual agreements are seamlessly integrated into your existing processes and that audit trails are fully traceable. This significantly reduces regulatory risks such as deviations during audits by notified bodies and creates clear responsibilities that facilitate audits. <\/p>\n
Our contracts precisely define which party is responsible for which aspects of product safety, vigilance and post-market surveillance. This is particularly important in complex supply chains or OEM-PLM constellations, where the MDR imposes significantly stricter requirements than the previous MDD. We also take into account liability aspects and product liability risks, which will become even more relevant from December 2026 due to the new Product Liability Directive (EU) 2024\/2853. <\/p>\n<\/div><\/div><\/div>
<\/span><\/div><\/div><\/div>Supplier and service contracts: Quality assurance agreements under the MDR<\/h2><\/div>Supplier contracts in the MedTech sector are subject to special requirements, as suppliers have a direct influence on product quality and therefore on patient safety. The MDR requires manufacturers to carry out a risk-based assessment and qualification of their suppliers as well as complete documentation of these processes. Quality assurance agreements (QAAs) are central components of the quality management system in accordance with MDR and ISO 13485. <\/p>\n
We design and review quality assurance agreements that contain all the elements required by regulations: Product quality requirements, test procedures and acceptance criteria, documentation obligations and change management, audit rights and monitoring mechanisms, traceability in accordance with Article 25 MDR as well as regulations on supplier evaluation and re-evaluation. Particularly important is the consideration of Article 120 (3) MDR, which places specific requirements on contracts with economic operators that have to be implemented since May 2021. <\/p>\n
Our quality assurance agreements are designed to be MDR-compliant and can be seamlessly integrated into your existing QM system. We support you in risk-based supplier selection in accordance with ISO 14971 and define clear processes for monitoring and re-evaluating suppliers in the contract. If desired, we can assume overall responsibility as a legal manufacturer and ensure that your supplier contracts fully reflect the regulatory chain of responsibility. This is particularly relevant if critical product components or processes are outsourced or if suppliers themselves do not have ISO 13485 certification. <\/p>\n<\/div>
Contracts for clinical trials: CRO contracts, sponsor obligations and subcontractors<\/h2><\/div>Clinical trials are required much more frequently under the MDR than under the previous MDD, particularly for products in risk class III and implantable devices. The contractual design of clinical trial agreements, CRO service contracts and subcontractor agreements is complex and requires precise regulations on responsibilities and regulatory obligations. <\/p>\n<\/div><\/div><\/div>
- <\/i><\/span>\n
Contracts with contract research organizations (CROs) and trial sites must clearly describe delegated sponsor obligations, quality requirements according to GCP (Good Clinical Practice) and ISO 14155, data integrity and data protection according to GDPR, safety reporting and vigilance obligations as well as monitoring and audit rights. A key question here is whether the CRO concludes contracts with trial sites in its own name or in the name of the sponsor, how changes to the study protocol are approved and how sponsor rights can be enforced in the event of deviations or breaches of contract. <\/p>\n<\/div><\/li>
- <\/i><\/span>\n
The use of subcontractors by CROs requires special attention. Contracts must contain clear reservations of consent by the sponsor, regulate the transfer of regulatory obligations to subcontractors and ensure that accountability to the sponsor is maintained. We structure and review clinical trial agreements, CRO service contracts and subcontractor agreements with a focus on regulatory compliance and liability reduction. In doing so, we systematically check the alignment of contracts with study protocols, GCP requirements and regulatory obligations as a sponsor or legal manufacturer. <\/p>\n<\/div><\/li>
- <\/i><\/span>\n
A particularly critical aspect is the definition of clear communication and escalation paths in the event of deviations, serious adverse events (SAE\/SADE) and audit findings. We define in the contract who has to inform which bodies and when, how reporting obligations to authorities and ethics committees are fulfilled and how these processes are documented. This prevents gaps in responsibility and ensures that all parties involved can fulfill their regulatory obligations in good time. <\/p>\n<\/div><\/li><\/ul><\/div><\/div>
Contact us<\/h3><\/div>Are you planning to place a medical device on the market and looking for an experienced legal manufacturer? Contact us for a non-binding consultation. Together we will develop the right strategy for your medical device. <\/p>\n<\/div>
Your contact to us<\/span><\/a><\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div><\/div>Ongoing contract and compliance management throughout the product life cycle<\/h2><\/div><\/div><\/div>Contracts are not static documents. They must be regularly reviewed and adapted to new regulatory requirements, updated standards and changes to internal processes. MDR updates, new MDCG guidelines, changes in harmonized standards or QMS adjustments may require contract amendments. Systematic contract management is therefore essential for audit and inspection capability and contributes to continuous compliance throughout the entire product life cycle. <\/p>\n
We organize a structured contract register with compliance relevance for you that links contracts with products, processes and risk assessments. This register enables you to track which contractual regulations apply to which products at any time, when contracts expire and where action is required. <\/p>\n<\/div><\/div><\/div>
\nWe undertake periodic contract reviews, implement trigger monitoring for regulatory changes, supplier changes or CAPAs and derive any necessary adjustments. This prevents contracts from becoming outdated or conflicting with current regulatory requirements. <\/p>\n<\/div>\n
The preparation and monitoring of audits and inspections is particularly important. Notified bodies and authorities regularly check how contracts support your quality, vigilance and compliance processes. We support you in providing evidence and prepare the relevant contract documents in such a way that auditors can quickly verify compliance. Our lifecycle approach ensures that your contract management remains consistent and compliant even in the event of product changes, expansions to the product portfolio or market entries into new regions. <\/p>\n<\/div><\/div><\/div>
BAYOOCARE as your partner for regulatory
\ncontract management<\/p><\/h2><\/div><\/div><\/div>
Our contract management combines regulatory expertise with practical implementation experience as a legal manufacturer. We not only understand the requirements of the MDR, ISO 13485 and other relevant regulations in theory, but also live them every day in our own responsibility for medical devices. This unique perspective enables us to draft contracts that are not only formally correct, but also work in everyday operations and can be lived by all parties involved. <\/p>\n
Our range of services includes the conception, creation and review of all contract-relevant documents in the MedTech sector. We structure complex contractual landscapes for supply chains, OEM-PLM constellations or international distribution structures. We assist you in contract negotiations with suppliers, CROs or sales partners and ensure that minimum regulatory requirements are met. If desired, we can assume overall responsibility as a legal manufacturer and act as a contracting party ourselves if this is advantageous for your market strategy or compliance structure. <\/p>\n
Our support in integrating contract management into your existing systems is particularly valuable. We link contracts with your QMS, your risk management documentation and your technical documentation so that consistent and seamless verification is possible. This integrated approach minimizes audit risks and creates the basis for sustainable compliance that will also withstand future regulatory changes. <\/p>\n<\/div><\/div><\/div>
Your next steps<\/h2><\/div>Would you like to make your contract landscape MDR-compliant, have existing contracts checked for compliance or need support with complex contract negotiations? Contact us for a non-binding consultation. We will analyse your specific situation and work with you to develop a solution that minimizes your regulatory risks and strengthens your compliance structure in the long term. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
Frequently asked questions<\/h2><\/div><\/div><\/div>Contract management raises many questions. We have answered the most common ones for you. Your question is not listed? Please feel free to contact us. <\/p>\n<\/div><\/div><\/div>
<\/span><\/div><\/div><\/div><\/i><\/i><\/span>What is a quality assurance agreement (QAA) and why is it necessary for medical devices?<\/span><\/a><\/h4><\/div>A quality assurance agreement is a contract between the manufacturer and supplier that regulates all quality-related requirements, test procedures and responsibilities. The MDR and ISO 13485 require manufacturers to carry out a documented, risk-based assessment of their suppliers and to contractually safeguard all outsourced processes. QAAs precisely define which quality standards the supplier must comply with and create the legal basis for audits and change management. <\/div><\/div><\/div><\/i><\/i><\/span>How has the MDR changed the requirements for contracts with suppliers?<\/span><\/a><\/h4><\/div>\nThe MDR has significantly tightened the requirements. The former Article 11(7) of the MDD, which allowed for simplified OEM PLM regulations, has been removed. Today, every economic operator whose name appears on the packaging bears full manufacturer responsibility, including their own conformity assessment procedure. Contracts must therefore regulate in detail who is responsible for technical documentation, vigilance, post-market surveillance and UDI registration. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>What must a contract with a CRO for clinical trials contain?<\/span><\/a><\/h4><\/div>\nA CRO agreement must precisely describe all tasks delegated by the sponsor, including study planning, monitoring, data management and safety reporting. Compliance with GCP and ISO 14155, responsibilities for contracts with trial sites, audit rights of the sponsor and regulations on data ownership and subcontractor use are key. The contract should also define clear escalation paths in the event of protocol deviations or serious adverse events. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>How often do medical device contracts need to be reviewed and updated?<\/span><\/a><\/h4><\/div>\nContracts should be reviewed both on an ad hoc and periodic basis. Occasions include changes to regulations such as MDR updates, product changes, QMS adjustments or audit findings with CAPAs. We recommend a periodic review at least every two to three years, especially for critical suppliers and CRO contracts. A structured contract register with trigger monitoring helps to identify and implement necessary updates in good time. <\/p>\n<\/div><\/div><\/div>
As a legal manufacturer, we at BAYOOCARE not only assume an advisory function, but also bear regulatory responsibility for medical devices ourselves. This perspective distinguishes us fundamentally from pure consulting service providers. We know from our own experience which contractual regulations work in practice, which risks notified bodies scrutinize in audits and how contracts must be structured in order not only to be formally correct, but also to be implemented in day-to-day business. <\/p>\n<\/div>
<\/span><\/div><\/div><\/div><\/div><\/div>In the medical device sector, contracts are far more than just commercial agreements. They are an integral part of your compliance structure and must reflect the requirements of the Medical Device Regulation (MDR), the Medical Device Law Implementation Act (MPDG), ISO 13485 and, where applicable, FDA regulations in a legally compliant manner. The regulatory requirements for medical devices have increased considerably in recent years. When the MDR came into force on May 26, 2021, the obligations for all economic operators along the supply chain were redefined and tightened. Article 10 MDR in particular requires manufacturers to establish and maintain a documented quality management system, which also includes the contractual management of all outsourced processes and supplier relationships. <\/p>\n
Our contract management translates regulatory requirements into practicable, audit-proof and resilient agreements that clearly define responsibilities and strengthen your compliance structure in the long term.<\/p>\n<\/div>
Preparation and review of regulatory contracts<\/h2><\/div>Every contract in the medical device sector must ensure that all parties involved can fulfill their legal and normative obligations. We draw up and review contracts taking into account the specific requirements of your product, your risk class and your market region. We systematically take into account the requirements of MDR Article 10 (QMS requirements), ISO 13485 (quality management) and ISO 14971 (risk management) in order to translate regulatory and technical requirements into clear contractual obligations, documentation requirements and escalation paths. <\/p>\n
A key benefit of our legal manufacturer perspective is that we ensure consistency between your contracts, your quality management system and your technical documentation. Contracts that are developed in isolation from the QMS often lead to inconsistencies that become problematic in audits. We ensure that contractual agreements are seamlessly integrated into your existing processes and that audit trails are fully traceable. This significantly reduces regulatory risks such as deviations during audits by notified bodies and creates clear responsibilities that facilitate audits. <\/p>\n
Our contracts precisely define which party is responsible for which aspects of product safety, vigilance and post-market surveillance. This is particularly important in complex supply chains or OEM-PLM constellations, where the MDR imposes significantly stricter requirements than the previous MDD. We also take into account liability aspects and product liability risks, which will become even more relevant from December 2026 due to the new Product Liability Directive (EU) 2024\/2853. <\/p>\n<\/div><\/div><\/div>
<\/span><\/div><\/div><\/div>Supplier and service contracts: Quality assurance agreements under the MDR<\/h2><\/div>Supplier contracts in the MedTech sector are subject to special requirements, as suppliers have a direct influence on product quality and therefore on patient safety. The MDR requires manufacturers to carry out a risk-based assessment and qualification of their suppliers as well as complete documentation of these processes. Quality assurance agreements (QAAs) are central components of the quality management system in accordance with MDR and ISO 13485. <\/p>\n
We design and review quality assurance agreements that contain all the elements required by regulations: Product quality requirements, test procedures and acceptance criteria, documentation obligations and change management, audit rights and monitoring mechanisms, traceability in accordance with Article 25 MDR as well as regulations on supplier evaluation and re-evaluation. Particularly important is the consideration of Article 120 (3) MDR, which places specific requirements on contracts with economic operators that have to be implemented since May 2021. <\/p>\n
Our quality assurance agreements are designed to be MDR-compliant and can be seamlessly integrated into your existing QM system. We support you in risk-based supplier selection in accordance with ISO 14971 and define clear processes for monitoring and re-evaluating suppliers in the contract. If desired, we can assume overall responsibility as a legal manufacturer and ensure that your supplier contracts fully reflect the regulatory chain of responsibility. This is particularly relevant if critical product components or processes are outsourced or if suppliers themselves do not have ISO 13485 certification. <\/p>\n<\/div>
Contracts for clinical trials: CRO contracts, sponsor obligations and subcontractors<\/h2><\/div>Clinical trials are required much more frequently under the MDR than under the previous MDD, particularly for products in risk class III and implantable devices. The contractual design of clinical trial agreements, CRO service contracts and subcontractor agreements is complex and requires precise regulations on responsibilities and regulatory obligations. <\/p>\n<\/div><\/div><\/div>
- <\/i><\/span>\n
Contracts with contract research organizations (CROs) and trial sites must clearly describe delegated sponsor obligations, quality requirements according to GCP (Good Clinical Practice) and ISO 14155, data integrity and data protection according to GDPR, safety reporting and vigilance obligations as well as monitoring and audit rights. A key question here is whether the CRO concludes contracts with trial sites in its own name or in the name of the sponsor, how changes to the study protocol are approved and how sponsor rights can be enforced in the event of deviations or breaches of contract. <\/p>\n<\/div><\/li>
- <\/i><\/span>\n
The use of subcontractors by CROs requires special attention. Contracts must contain clear reservations of consent by the sponsor, regulate the transfer of regulatory obligations to subcontractors and ensure that accountability to the sponsor is maintained. We structure and review clinical trial agreements, CRO service contracts and subcontractor agreements with a focus on regulatory compliance and liability reduction. In doing so, we systematically check the alignment of contracts with study protocols, GCP requirements and regulatory obligations as a sponsor or legal manufacturer. <\/p>\n<\/div><\/li>
- <\/i><\/span>\n
A particularly critical aspect is the definition of clear communication and escalation paths in the event of deviations, serious adverse events (SAE\/SADE) and audit findings. We define in the contract who has to inform which bodies and when, how reporting obligations to authorities and ethics committees are fulfilled and how these processes are documented. This prevents gaps in responsibility and ensures that all parties involved can fulfill their regulatory obligations in good time. <\/p>\n<\/div><\/li><\/ul><\/div><\/div>
Contact us<\/h3><\/div>Are you planning to place a medical device on the market and looking for an experienced legal manufacturer? Contact us for a non-binding consultation. Together we will develop the right strategy for your medical device. <\/p>\n<\/div>
Your contact to us<\/span><\/a><\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div><\/div>Ongoing contract and compliance management throughout the product life cycle<\/h2><\/div><\/div><\/div>Contracts are not static documents. They must be regularly reviewed and adapted to new regulatory requirements, updated standards and changes to internal processes. MDR updates, new MDCG guidelines, changes in harmonized standards or QMS adjustments may require contract amendments. Systematic contract management is therefore essential for audit and inspection capability and contributes to continuous compliance throughout the entire product life cycle. <\/p>\n
We organize a structured contract register with compliance relevance for you that links contracts with products, processes and risk assessments. This register enables you to track which contractual regulations apply to which products at any time, when contracts expire and where action is required. <\/p>\n<\/div><\/div><\/div>
\nWe undertake periodic contract reviews, implement trigger monitoring for regulatory changes, supplier changes or CAPAs and derive any necessary adjustments. This prevents contracts from becoming outdated or conflicting with current regulatory requirements. <\/p>\n<\/div>\n
The preparation and monitoring of audits and inspections is particularly important. Notified bodies and authorities regularly check how contracts support your quality, vigilance and compliance processes. We support you in providing evidence and prepare the relevant contract documents in such a way that auditors can quickly verify compliance. Our lifecycle approach ensures that your contract management remains consistent and compliant even in the event of product changes, expansions to the product portfolio or market entries into new regions. <\/p>\n<\/div><\/div><\/div>
BAYOOCARE as your partner for regulatory
\ncontract management<\/p><\/h2><\/div><\/div><\/div>
Our contract management combines regulatory expertise with practical implementation experience as a legal manufacturer. We not only understand the requirements of the MDR, ISO 13485 and other relevant regulations in theory, but also live them every day in our own responsibility for medical devices. This unique perspective enables us to draft contracts that are not only formally correct, but also work in everyday operations and can be lived by all parties involved. <\/p>\n
Our range of services includes the conception, creation and review of all contract-relevant documents in the MedTech sector. We structure complex contractual landscapes for supply chains, OEM-PLM constellations or international distribution structures. We assist you in contract negotiations with suppliers, CROs or sales partners and ensure that minimum regulatory requirements are met. If desired, we can assume overall responsibility as a legal manufacturer and act as a contracting party ourselves if this is advantageous for your market strategy or compliance structure. <\/p>\n
Our support in integrating contract management into your existing systems is particularly valuable. We link contracts with your QMS, your risk management documentation and your technical documentation so that consistent and seamless verification is possible. This integrated approach minimizes audit risks and creates the basis for sustainable compliance that will also withstand future regulatory changes. <\/p>\n<\/div><\/div><\/div>
Your next steps<\/h2><\/div>Would you like to make your contract landscape MDR-compliant, have existing contracts checked for compliance or need support with complex contract negotiations? Contact us for a non-binding consultation. We will analyse your specific situation and work with you to develop a solution that minimizes your regulatory risks and strengthens your compliance structure in the long term. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
Frequently asked questions<\/h2><\/div><\/div><\/div>Contract management raises many questions. We have answered the most common ones for you. Your question is not listed? Please feel free to contact us. <\/p>\n<\/div><\/div><\/div>
<\/span><\/div><\/div><\/div><\/i><\/i><\/span>What is a quality assurance agreement (QAA) and why is it necessary for medical devices?<\/span><\/a><\/h4><\/div>A quality assurance agreement is a contract between the manufacturer and supplier that regulates all quality-related requirements, test procedures and responsibilities. The MDR and ISO 13485 require manufacturers to carry out a documented, risk-based assessment of their suppliers and to contractually safeguard all outsourced processes. QAAs precisely define which quality standards the supplier must comply with and create the legal basis for audits and change management. <\/div><\/div><\/div><\/i><\/i><\/span>How has the MDR changed the requirements for contracts with suppliers?<\/span><\/a><\/h4><\/div>\nThe MDR has significantly tightened the requirements. The former Article 11(7) of the MDD, which allowed for simplified OEM PLM regulations, has been removed. Today, every economic operator whose name appears on the packaging bears full manufacturer responsibility, including their own conformity assessment procedure. Contracts must therefore regulate in detail who is responsible for technical documentation, vigilance, post-market surveillance and UDI registration. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>What must a contract with a CRO for clinical trials contain?<\/span><\/a><\/h4><\/div>\nA CRO agreement must precisely describe all tasks delegated by the sponsor, including study planning, monitoring, data management and safety reporting. Compliance with GCP and ISO 14155, responsibilities for contracts with trial sites, audit rights of the sponsor and regulations on data ownership and subcontractor use are key. The contract should also define clear escalation paths in the event of protocol deviations or serious adverse events. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>How often do medical device contracts need to be reviewed and updated?<\/span><\/a><\/h4><\/div>\nContracts should be reviewed both on an ad hoc and periodic basis. Occasions include changes to regulations such as MDR updates, product changes, QMS adjustments or audit findings with CAPAs. We recommend a periodic review at least every two to three years, especially for critical suppliers and CRO contracts. A structured contract register with trigger monitoring helps to identify and implement necessary updates in good time. <\/p>\n<\/div><\/div><\/div>
Every contract in the medical device sector must ensure that all parties involved can fulfill their legal and normative obligations. We draw up and review contracts taking into account the specific requirements of your product, your risk class and your market region. We systematically take into account the requirements of MDR Article 10 (QMS requirements), ISO 13485 (quality management) and ISO 14971 (risk management) in order to translate regulatory and technical requirements into clear contractual obligations, documentation requirements and escalation paths. <\/p>\n
A key benefit of our legal manufacturer perspective is that we ensure consistency between your contracts, your quality management system and your technical documentation. Contracts that are developed in isolation from the QMS often lead to inconsistencies that become problematic in audits. We ensure that contractual agreements are seamlessly integrated into your existing processes and that audit trails are fully traceable. This significantly reduces regulatory risks such as deviations during audits by notified bodies and creates clear responsibilities that facilitate audits. <\/p>\n
Our contracts precisely define which party is responsible for which aspects of product safety, vigilance and post-market surveillance. This is particularly important in complex supply chains or OEM-PLM constellations, where the MDR imposes significantly stricter requirements than the previous MDD. We also take into account liability aspects and product liability risks, which will become even more relevant from December 2026 due to the new Product Liability Directive (EU) 2024\/2853. <\/p>\n<\/div><\/div><\/div>
<\/span><\/div><\/div><\/div>Supplier and service contracts: Quality assurance agreements under the MDR<\/h2><\/div>Supplier contracts in the MedTech sector are subject to special requirements, as suppliers have a direct influence on product quality and therefore on patient safety. The MDR requires manufacturers to carry out a risk-based assessment and qualification of their suppliers as well as complete documentation of these processes. Quality assurance agreements (QAAs) are central components of the quality management system in accordance with MDR and ISO 13485. <\/p>\n
We design and review quality assurance agreements that contain all the elements required by regulations: Product quality requirements, test procedures and acceptance criteria, documentation obligations and change management, audit rights and monitoring mechanisms, traceability in accordance with Article 25 MDR as well as regulations on supplier evaluation and re-evaluation. Particularly important is the consideration of Article 120 (3) MDR, which places specific requirements on contracts with economic operators that have to be implemented since May 2021. <\/p>\n
Our quality assurance agreements are designed to be MDR-compliant and can be seamlessly integrated into your existing QM system. We support you in risk-based supplier selection in accordance with ISO 14971 and define clear processes for monitoring and re-evaluating suppliers in the contract. If desired, we can assume overall responsibility as a legal manufacturer and ensure that your supplier contracts fully reflect the regulatory chain of responsibility. This is particularly relevant if critical product components or processes are outsourced or if suppliers themselves do not have ISO 13485 certification. <\/p>\n<\/div>
Contracts for clinical trials: CRO contracts, sponsor obligations and subcontractors<\/h2><\/div>Clinical trials are required much more frequently under the MDR than under the previous MDD, particularly for products in risk class III and implantable devices. The contractual design of clinical trial agreements, CRO service contracts and subcontractor agreements is complex and requires precise regulations on responsibilities and regulatory obligations. <\/p>\n<\/div><\/div><\/div>
- <\/i><\/span>\n
Contracts with contract research organizations (CROs) and trial sites must clearly describe delegated sponsor obligations, quality requirements according to GCP (Good Clinical Practice) and ISO 14155, data integrity and data protection according to GDPR, safety reporting and vigilance obligations as well as monitoring and audit rights. A key question here is whether the CRO concludes contracts with trial sites in its own name or in the name of the sponsor, how changes to the study protocol are approved and how sponsor rights can be enforced in the event of deviations or breaches of contract. <\/p>\n<\/div><\/li>
- <\/i><\/span>\n
The use of subcontractors by CROs requires special attention. Contracts must contain clear reservations of consent by the sponsor, regulate the transfer of regulatory obligations to subcontractors and ensure that accountability to the sponsor is maintained. We structure and review clinical trial agreements, CRO service contracts and subcontractor agreements with a focus on regulatory compliance and liability reduction. In doing so, we systematically check the alignment of contracts with study protocols, GCP requirements and regulatory obligations as a sponsor or legal manufacturer. <\/p>\n<\/div><\/li>
- <\/i><\/span>\n
A particularly critical aspect is the definition of clear communication and escalation paths in the event of deviations, serious adverse events (SAE\/SADE) and audit findings. We define in the contract who has to inform which bodies and when, how reporting obligations to authorities and ethics committees are fulfilled and how these processes are documented. This prevents gaps in responsibility and ensures that all parties involved can fulfill their regulatory obligations in good time. <\/p>\n<\/div><\/li><\/ul><\/div><\/div>
Contact us<\/h3><\/div>Are you planning to place a medical device on the market and looking for an experienced legal manufacturer? Contact us for a non-binding consultation. Together we will develop the right strategy for your medical device. <\/p>\n<\/div>
Your contact to us<\/span><\/a><\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div><\/div>Ongoing contract and compliance management throughout the product life cycle<\/h2><\/div><\/div><\/div>Contracts are not static documents. They must be regularly reviewed and adapted to new regulatory requirements, updated standards and changes to internal processes. MDR updates, new MDCG guidelines, changes in harmonized standards or QMS adjustments may require contract amendments. Systematic contract management is therefore essential for audit and inspection capability and contributes to continuous compliance throughout the entire product life cycle. <\/p>\n
We organize a structured contract register with compliance relevance for you that links contracts with products, processes and risk assessments. This register enables you to track which contractual regulations apply to which products at any time, when contracts expire and where action is required. <\/p>\n<\/div><\/div><\/div>
\nWe undertake periodic contract reviews, implement trigger monitoring for regulatory changes, supplier changes or CAPAs and derive any necessary adjustments. This prevents contracts from becoming outdated or conflicting with current regulatory requirements. <\/p>\n<\/div>\n
The preparation and monitoring of audits and inspections is particularly important. Notified bodies and authorities regularly check how contracts support your quality, vigilance and compliance processes. We support you in providing evidence and prepare the relevant contract documents in such a way that auditors can quickly verify compliance. Our lifecycle approach ensures that your contract management remains consistent and compliant even in the event of product changes, expansions to the product portfolio or market entries into new regions. <\/p>\n<\/div><\/div><\/div>
BAYOOCARE as your partner for regulatory
\ncontract management<\/p><\/h2><\/div><\/div><\/div>
Our contract management combines regulatory expertise with practical implementation experience as a legal manufacturer. We not only understand the requirements of the MDR, ISO 13485 and other relevant regulations in theory, but also live them every day in our own responsibility for medical devices. This unique perspective enables us to draft contracts that are not only formally correct, but also work in everyday operations and can be lived by all parties involved. <\/p>\n
Our range of services includes the conception, creation and review of all contract-relevant documents in the MedTech sector. We structure complex contractual landscapes for supply chains, OEM-PLM constellations or international distribution structures. We assist you in contract negotiations with suppliers, CROs or sales partners and ensure that minimum regulatory requirements are met. If desired, we can assume overall responsibility as a legal manufacturer and act as a contracting party ourselves if this is advantageous for your market strategy or compliance structure. <\/p>\n
Our support in integrating contract management into your existing systems is particularly valuable. We link contracts with your QMS, your risk management documentation and your technical documentation so that consistent and seamless verification is possible. This integrated approach minimizes audit risks and creates the basis for sustainable compliance that will also withstand future regulatory changes. <\/p>\n<\/div><\/div><\/div>
Your next steps<\/h2><\/div>Would you like to make your contract landscape MDR-compliant, have existing contracts checked for compliance or need support with complex contract negotiations? Contact us for a non-binding consultation. We will analyse your specific situation and work with you to develop a solution that minimizes your regulatory risks and strengthens your compliance structure in the long term. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
Frequently asked questions<\/h2><\/div><\/div><\/div>Contract management raises many questions. We have answered the most common ones for you. Your question is not listed? Please feel free to contact us. <\/p>\n<\/div><\/div><\/div>
<\/span><\/div><\/div><\/div><\/i><\/i><\/span>What is a quality assurance agreement (QAA) and why is it necessary for medical devices?<\/span><\/a><\/h4><\/div>A quality assurance agreement is a contract between the manufacturer and supplier that regulates all quality-related requirements, test procedures and responsibilities. The MDR and ISO 13485 require manufacturers to carry out a documented, risk-based assessment of their suppliers and to contractually safeguard all outsourced processes. QAAs precisely define which quality standards the supplier must comply with and create the legal basis for audits and change management. <\/div><\/div><\/div><\/i><\/i><\/span>How has the MDR changed the requirements for contracts with suppliers?<\/span><\/a><\/h4><\/div>\nThe MDR has significantly tightened the requirements. The former Article 11(7) of the MDD, which allowed for simplified OEM PLM regulations, has been removed. Today, every economic operator whose name appears on the packaging bears full manufacturer responsibility, including their own conformity assessment procedure. Contracts must therefore regulate in detail who is responsible for technical documentation, vigilance, post-market surveillance and UDI registration. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>What must a contract with a CRO for clinical trials contain?<\/span><\/a><\/h4><\/div>\nA CRO agreement must precisely describe all tasks delegated by the sponsor, including study planning, monitoring, data management and safety reporting. Compliance with GCP and ISO 14155, responsibilities for contracts with trial sites, audit rights of the sponsor and regulations on data ownership and subcontractor use are key. The contract should also define clear escalation paths in the event of protocol deviations or serious adverse events. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>How often do medical device contracts need to be reviewed and updated?<\/span><\/a><\/h4><\/div>\nContracts should be reviewed both on an ad hoc and periodic basis. Occasions include changes to regulations such as MDR updates, product changes, QMS adjustments or audit findings with CAPAs. We recommend a periodic review at least every two to three years, especially for critical suppliers and CRO contracts. A structured contract register with trigger monitoring helps to identify and implement necessary updates in good time. <\/p>\n<\/div><\/div><\/div>
Supplier contracts in the MedTech sector are subject to special requirements, as suppliers have a direct influence on product quality and therefore on patient safety. The MDR requires manufacturers to carry out a risk-based assessment and qualification of their suppliers as well as complete documentation of these processes. Quality assurance agreements (QAAs) are central components of the quality management system in accordance with MDR and ISO 13485. <\/p>\n
We design and review quality assurance agreements that contain all the elements required by regulations: Product quality requirements, test procedures and acceptance criteria, documentation obligations and change management, audit rights and monitoring mechanisms, traceability in accordance with Article 25 MDR as well as regulations on supplier evaluation and re-evaluation. Particularly important is the consideration of Article 120 (3) MDR, which places specific requirements on contracts with economic operators that have to be implemented since May 2021. <\/p>\n
Our quality assurance agreements are designed to be MDR-compliant and can be seamlessly integrated into your existing QM system. We support you in risk-based supplier selection in accordance with ISO 14971 and define clear processes for monitoring and re-evaluating suppliers in the contract. If desired, we can assume overall responsibility as a legal manufacturer and ensure that your supplier contracts fully reflect the regulatory chain of responsibility. This is particularly relevant if critical product components or processes are outsourced or if suppliers themselves do not have ISO 13485 certification. <\/p>\n<\/div>
Contracts for clinical trials: CRO contracts, sponsor obligations and subcontractors<\/h2><\/div>Clinical trials are required much more frequently under the MDR than under the previous MDD, particularly for products in risk class III and implantable devices. The contractual design of clinical trial agreements, CRO service contracts and subcontractor agreements is complex and requires precise regulations on responsibilities and regulatory obligations. <\/p>\n<\/div><\/div><\/div>
- <\/i><\/span>\n
Contracts with contract research organizations (CROs) and trial sites must clearly describe delegated sponsor obligations, quality requirements according to GCP (Good Clinical Practice) and ISO 14155, data integrity and data protection according to GDPR, safety reporting and vigilance obligations as well as monitoring and audit rights. A key question here is whether the CRO concludes contracts with trial sites in its own name or in the name of the sponsor, how changes to the study protocol are approved and how sponsor rights can be enforced in the event of deviations or breaches of contract. <\/p>\n<\/div><\/li>
- <\/i><\/span>\n
The use of subcontractors by CROs requires special attention. Contracts must contain clear reservations of consent by the sponsor, regulate the transfer of regulatory obligations to subcontractors and ensure that accountability to the sponsor is maintained. We structure and review clinical trial agreements, CRO service contracts and subcontractor agreements with a focus on regulatory compliance and liability reduction. In doing so, we systematically check the alignment of contracts with study protocols, GCP requirements and regulatory obligations as a sponsor or legal manufacturer. <\/p>\n<\/div><\/li>
- <\/i><\/span>\n
A particularly critical aspect is the definition of clear communication and escalation paths in the event of deviations, serious adverse events (SAE\/SADE) and audit findings. We define in the contract who has to inform which bodies and when, how reporting obligations to authorities and ethics committees are fulfilled and how these processes are documented. This prevents gaps in responsibility and ensures that all parties involved can fulfill their regulatory obligations in good time. <\/p>\n<\/div><\/li><\/ul><\/div><\/div>
Contact us<\/h3><\/div>Are you planning to place a medical device on the market and looking for an experienced legal manufacturer? Contact us for a non-binding consultation. Together we will develop the right strategy for your medical device. <\/p>\n<\/div>
Your contact to us<\/span><\/a><\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div><\/div>Ongoing contract and compliance management throughout the product life cycle<\/h2><\/div><\/div><\/div>Contracts are not static documents. They must be regularly reviewed and adapted to new regulatory requirements, updated standards and changes to internal processes. MDR updates, new MDCG guidelines, changes in harmonized standards or QMS adjustments may require contract amendments. Systematic contract management is therefore essential for audit and inspection capability and contributes to continuous compliance throughout the entire product life cycle. <\/p>\n
We organize a structured contract register with compliance relevance for you that links contracts with products, processes and risk assessments. This register enables you to track which contractual regulations apply to which products at any time, when contracts expire and where action is required. <\/p>\n<\/div><\/div><\/div>
\nWe undertake periodic contract reviews, implement trigger monitoring for regulatory changes, supplier changes or CAPAs and derive any necessary adjustments. This prevents contracts from becoming outdated or conflicting with current regulatory requirements. <\/p>\n<\/div>\n
The preparation and monitoring of audits and inspections is particularly important. Notified bodies and authorities regularly check how contracts support your quality, vigilance and compliance processes. We support you in providing evidence and prepare the relevant contract documents in such a way that auditors can quickly verify compliance. Our lifecycle approach ensures that your contract management remains consistent and compliant even in the event of product changes, expansions to the product portfolio or market entries into new regions. <\/p>\n<\/div><\/div><\/div>
BAYOOCARE as your partner for regulatory
\ncontract management<\/p><\/h2><\/div><\/div><\/div>
Our contract management combines regulatory expertise with practical implementation experience as a legal manufacturer. We not only understand the requirements of the MDR, ISO 13485 and other relevant regulations in theory, but also live them every day in our own responsibility for medical devices. This unique perspective enables us to draft contracts that are not only formally correct, but also work in everyday operations and can be lived by all parties involved. <\/p>\n
Our range of services includes the conception, creation and review of all contract-relevant documents in the MedTech sector. We structure complex contractual landscapes for supply chains, OEM-PLM constellations or international distribution structures. We assist you in contract negotiations with suppliers, CROs or sales partners and ensure that minimum regulatory requirements are met. If desired, we can assume overall responsibility as a legal manufacturer and act as a contracting party ourselves if this is advantageous for your market strategy or compliance structure. <\/p>\n
Our support in integrating contract management into your existing systems is particularly valuable. We link contracts with your QMS, your risk management documentation and your technical documentation so that consistent and seamless verification is possible. This integrated approach minimizes audit risks and creates the basis for sustainable compliance that will also withstand future regulatory changes. <\/p>\n<\/div><\/div><\/div>
Your next steps<\/h2><\/div>Would you like to make your contract landscape MDR-compliant, have existing contracts checked for compliance or need support with complex contract negotiations? Contact us for a non-binding consultation. We will analyse your specific situation and work with you to develop a solution that minimizes your regulatory risks and strengthens your compliance structure in the long term. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
Frequently asked questions<\/h2><\/div><\/div><\/div>Contract management raises many questions. We have answered the most common ones for you. Your question is not listed? Please feel free to contact us. <\/p>\n<\/div><\/div><\/div>
<\/span><\/div><\/div><\/div><\/i><\/i><\/span>What is a quality assurance agreement (QAA) and why is it necessary for medical devices?<\/span><\/a><\/h4><\/div>A quality assurance agreement is a contract between the manufacturer and supplier that regulates all quality-related requirements, test procedures and responsibilities. The MDR and ISO 13485 require manufacturers to carry out a documented, risk-based assessment of their suppliers and to contractually safeguard all outsourced processes. QAAs precisely define which quality standards the supplier must comply with and create the legal basis for audits and change management. <\/div><\/div><\/div><\/i><\/i><\/span>How has the MDR changed the requirements for contracts with suppliers?<\/span><\/a><\/h4><\/div>\nThe MDR has significantly tightened the requirements. The former Article 11(7) of the MDD, which allowed for simplified OEM PLM regulations, has been removed. Today, every economic operator whose name appears on the packaging bears full manufacturer responsibility, including their own conformity assessment procedure. Contracts must therefore regulate in detail who is responsible for technical documentation, vigilance, post-market surveillance and UDI registration. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>What must a contract with a CRO for clinical trials contain?<\/span><\/a><\/h4><\/div>\nA CRO agreement must precisely describe all tasks delegated by the sponsor, including study planning, monitoring, data management and safety reporting. Compliance with GCP and ISO 14155, responsibilities for contracts with trial sites, audit rights of the sponsor and regulations on data ownership and subcontractor use are key. The contract should also define clear escalation paths in the event of protocol deviations or serious adverse events. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>How often do medical device contracts need to be reviewed and updated?<\/span><\/a><\/h4><\/div>\nContracts should be reviewed both on an ad hoc and periodic basis. Occasions include changes to regulations such as MDR updates, product changes, QMS adjustments or audit findings with CAPAs. We recommend a periodic review at least every two to three years, especially for critical suppliers and CRO contracts. A structured contract register with trigger monitoring helps to identify and implement necessary updates in good time. <\/p>\n<\/div><\/div><\/div>
Clinical trials are required much more frequently under the MDR than under the previous MDD, particularly for products in risk class III and implantable devices. The contractual design of clinical trial agreements, CRO service contracts and subcontractor agreements is complex and requires precise regulations on responsibilities and regulatory obligations. <\/p>\n<\/div><\/div><\/div>
- <\/i><\/span>\n
Contracts with contract research organizations (CROs) and trial sites must clearly describe delegated sponsor obligations, quality requirements according to GCP (Good Clinical Practice) and ISO 14155, data integrity and data protection according to GDPR, safety reporting and vigilance obligations as well as monitoring and audit rights. A key question here is whether the CRO concludes contracts with trial sites in its own name or in the name of the sponsor, how changes to the study protocol are approved and how sponsor rights can be enforced in the event of deviations or breaches of contract. <\/p>\n<\/div><\/li>
- <\/i><\/span>
\nThe use of subcontractors by CROs requires special attention. Contracts must contain clear reservations of consent by the sponsor, regulate the transfer of regulatory obligations to subcontractors and ensure that accountability to the sponsor is maintained. We structure and review clinical trial agreements, CRO service contracts and subcontractor agreements with a focus on regulatory compliance and liability reduction. In doing so, we systematically check the alignment of contracts with study protocols, GCP requirements and regulatory obligations as a sponsor or legal manufacturer. <\/p>\n<\/div><\/li>
- <\/i><\/span>
\nA particularly critical aspect is the definition of clear communication and escalation paths in the event of deviations, serious adverse events (SAE\/SADE) and audit findings. We define in the contract who has to inform which bodies and when, how reporting obligations to authorities and ethics committees are fulfilled and how these processes are documented. This prevents gaps in responsibility and ensures that all parties involved can fulfill their regulatory obligations in good time. <\/p>\n<\/div><\/li><\/ul><\/div><\/div>
Contact us<\/h3><\/div>
Are you planning to place a medical device on the market and looking for an experienced legal manufacturer? Contact us for a non-binding consultation. Together we will develop the right strategy for your medical device. <\/p>\n<\/div>
Your contact to us<\/span><\/a><\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div><\/div>Ongoing contract and compliance management throughout the product life cycle<\/h2><\/div><\/div><\/div>
Contracts are not static documents. They must be regularly reviewed and adapted to new regulatory requirements, updated standards and changes to internal processes. MDR updates, new MDCG guidelines, changes in harmonized standards or QMS adjustments may require contract amendments. Systematic contract management is therefore essential for audit and inspection capability and contributes to continuous compliance throughout the entire product life cycle. <\/p>\n
We organize a structured contract register with compliance relevance for you that links contracts with products, processes and risk assessments. This register enables you to track which contractual regulations apply to which products at any time, when contracts expire and where action is required. <\/p>\n<\/div><\/div><\/div>
\nWe undertake periodic contract reviews, implement trigger monitoring for regulatory changes, supplier changes or CAPAs and derive any necessary adjustments. This prevents contracts from becoming outdated or conflicting with current regulatory requirements. <\/p>\n<\/div>\n
The preparation and monitoring of audits and inspections is particularly important. Notified bodies and authorities regularly check how contracts support your quality, vigilance and compliance processes. We support you in providing evidence and prepare the relevant contract documents in such a way that auditors can quickly verify compliance. Our lifecycle approach ensures that your contract management remains consistent and compliant even in the event of product changes, expansions to the product portfolio or market entries into new regions. <\/p>\n<\/div><\/div><\/div>
BAYOOCARE as your partner for regulatory
\ncontract management<\/p><\/h2><\/div><\/div><\/div>Our contract management combines regulatory expertise with practical implementation experience as a legal manufacturer. We not only understand the requirements of the MDR, ISO 13485 and other relevant regulations in theory, but also live them every day in our own responsibility for medical devices. This unique perspective enables us to draft contracts that are not only formally correct, but also work in everyday operations and can be lived by all parties involved. <\/p>\n
Our range of services includes the conception, creation and review of all contract-relevant documents in the MedTech sector. We structure complex contractual landscapes for supply chains, OEM-PLM constellations or international distribution structures. We assist you in contract negotiations with suppliers, CROs or sales partners and ensure that minimum regulatory requirements are met. If desired, we can assume overall responsibility as a legal manufacturer and act as a contracting party ourselves if this is advantageous for your market strategy or compliance structure. <\/p>\n
Our support in integrating contract management into your existing systems is particularly valuable. We link contracts with your QMS, your risk management documentation and your technical documentation so that consistent and seamless verification is possible. This integrated approach minimizes audit risks and creates the basis for sustainable compliance that will also withstand future regulatory changes. <\/p>\n<\/div><\/div><\/div>
Your next steps<\/h2><\/div>
Would you like to make your contract landscape MDR-compliant, have existing contracts checked for compliance or need support with complex contract negotiations? Contact us for a non-binding consultation. We will analyse your specific situation and work with you to develop a solution that minimizes your regulatory risks and strengthens your compliance structure in the long term. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
Frequently asked questions<\/h2><\/div><\/div><\/div>
Contract management raises many questions. We have answered the most common ones for you. Your question is not listed? Please feel free to contact us. <\/p>\n<\/div><\/div><\/div>
<\/span><\/div><\/div><\/div><\/i><\/i><\/span>What is a quality assurance agreement (QAA) and why is it necessary for medical devices?<\/span><\/a><\/h4><\/div>
A quality assurance agreement is a contract between the manufacturer and supplier that regulates all quality-related requirements, test procedures and responsibilities. The MDR and ISO 13485 require manufacturers to carry out a documented, risk-based assessment of their suppliers and to contractually safeguard all outsourced processes. QAAs precisely define which quality standards the supplier must comply with and create the legal basis for audits and change management. <\/div><\/div><\/div><\/i><\/i><\/span>How has the MDR changed the requirements for contracts with suppliers?<\/span><\/a><\/h4><\/div>
\nThe MDR has significantly tightened the requirements. The former Article 11(7) of the MDD, which allowed for simplified OEM PLM regulations, has been removed. Today, every economic operator whose name appears on the packaging bears full manufacturer responsibility, including their own conformity assessment procedure. Contracts must therefore regulate in detail who is responsible for technical documentation, vigilance, post-market surveillance and UDI registration. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>What must a contract with a CRO for clinical trials contain?<\/span><\/a><\/h4><\/div>
\nA CRO agreement must precisely describe all tasks delegated by the sponsor, including study planning, monitoring, data management and safety reporting. Compliance with GCP and ISO 14155, responsibilities for contracts with trial sites, audit rights of the sponsor and regulations on data ownership and subcontractor use are key. The contract should also define clear escalation paths in the event of protocol deviations or serious adverse events. <\/p>\n<\/div><\/div><\/div>
<\/i><\/i><\/span>How often do medical device contracts need to be reviewed and updated?<\/span><\/a><\/h4><\/div>
\nContracts should be reviewed both on an ad hoc and periodic basis. Occasions include changes to regulations such as MDR updates, product changes, QMS adjustments or audit findings with CAPAs. We recommend a periodic review at least every two to three years, especially for critical suppliers and CRO contracts. A structured contract register with trigger monitoring helps to identify and implement necessary updates in good time. <\/p>\n<\/div><\/div><\/div>
- <\/i><\/span>
![\"BAYOOCARE](\"https:\/\/www.bayoocare.com\/wp-content\/uploads\/sites\/7\/2025\/01\/BAYOOCARE-Alfred-Koch-CEO-PRRC.png\" "\\"BAYOOCARE")
<\/span><\/div><\/div><\/div>